Grants per year
- 100 - 125 out of 138 results
Search results
-
Finished
Prot# 3151A4-327-US: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Adaptive-Design, Efficacy, Safety and Tolerability Study of 4 Fixed Oral Doses of DVS SR in Adult Outpatients with Fibromyalgia Syndrome
Schnitzer, T. J. (PD/PI)
8/4/06 → 10/13/08
Project: Research project
-
Prot# 3151A4-327-US: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Adaptive-Design, Efficacy, Safety and Tolerability Study of 4 Fixed Oral Doses of DVS SR in Adult Outpatients with Fibromyalgia Syndrome
Schnitzer, T. J. (PD/PI)
8/4/06 → 10/13/08
Project: Research project
-
Prot# HCT 3012-X-301: A Phs 3 Stdy of the Analgesic Efficacy & Sfty of HCT 3012: A Parallel, Randomized, Double-Blind, 13-Wk, Placebo-& Naproxen-Controlled, Multicenter Study of HCT 3012 (375 mg bid & 750 mg bid) in Ptnts w/Osteoarthritis of the Knee
Schnitzer, T. J. (PD/PI)
PRA Health Sciences, NicOx S.A.
5/3/06 → 12/21/06
Project: Research project
-
Prot# HCT 3012-X-301: A Phs 3 Stdy of the Analgesic Efficacy & Sfty of HCT 3012: A Parallel, Randomized, Double-Blind, 13-Wk, Placebo-& Naproxen-Controlled, Multicenter Study of HCT 3012 (375 mg bid & 750 mg bid) in Ptnts w/Osteoarthritis of the Knee
Schnitzer, T. J. (PD/PI)
PRA Health Sciences, NicOx S.A.
5/3/06 → 12/21/06
Project: Research project
-
Prot# CZOL446H2301E1: A 3-Year, Double-Blind Extension to CZOL446H2301 to Evaluate the Long Term Safety and Efficacy of Zoledronic Acid in the Treatment of Osteoporosis in Post-Menopausal Women Taking Calcium and Vitamin D
Schnitzer, T. J. (PD/PI)
Novartis Pharmaceuticals Corporation
10/7/05 → 3/31/08
Project: Research project
-
Prot# CXA30007: A Phs III,12-Wk,Mltcntr,Dbl-Blind,Dbl-Dummy,Randomised,Placebo-&Active Comparator-Controlled,Parallel Group Study to Investigate the Efficacy&Safety of GW406381 1mg,5mg,10mg,25mg&50mg Admin Orally 1x Daily,in Adults w/Osteoar
Schnitzer, T. J. (PD/PI)
8/8/05 → 10/30/06
Project: Research project
-
Prot# CXA30007: A Phs III,12-Wk,Mltcntr,Dbl-Blind,Dbl-Dummy,Randomised,Placebo-&Active Comparator-Controlled,Parallel Group Study to Investigate the Efficacy&Safety of GW406381 1mg,5mg,10mg,25mg&50mg Admin Orally 1x Daily,in Adults w/Osteoar
Schnitzer, T. J. (PD/PI)
8/8/05 → 10/30/06
Project: Research project
-
Prot# WA18063B: A Rndmzd, Dbl-Blnd, Plcb-Cntrlld, Prllel Grp Stdy of the Sfty & Rdctn of Sgn & Symptms Drng Trtmnt w/ MRA vs Plcb, In Cmbntn w/ Trdtnl DMARD Thrpy in Ptnts w/ Mdrt to Svre Actv Rhumtd Arthrts & an indqt rspns to crrnt DMARD Thrpy
Ruderman, E. M. (PD/PI) & Schnitzer, T. J. (Co-PD/PI)
7/11/05 → 9/10/10
Project: Research project
-
Prot# AVS00103: A Multicenter, Parallel, Double-Blind, Blinded Evaluator, Randomized Comparison of the Efficacy and Safety of an Alternate Viscosupplement (AVS-beta) to Methylprednisolone Acetate in Patients with Symptomatic Osteoarthritis of the Knee
Schnitzer, T. J. (PD/PI)
6/23/05 → 6/20/08
Project: Research project
-
Prot# AVS00103: A Multicenter, Parallel, Double-Blind, Blinded Evaluator, Randomized Comparison of the Efficacy and Safety of an Alternate Viscosupplement (AVS-beta) to Methylprednisolone Acetate in Patients with Symptomatic Osteoarthritis of the Knee
Schnitzer, T. J. (PD/PI)
6/23/05 → 6/20/08
Project: Research project
-
Prot# A9001140: A Longitudinal Study of Osteoarthritis (OA) Disease Progression Measured by MRI, dGEMRIC, and Radiography
Schnitzer, T. J. (PD/PI)
NorthShore University HealthSystem Research Institute, Pfizer Inc.
5/5/05 → 2/29/08
Project: Research project
-
Prot# A9001140: A Longitudinal Study of Osteoarthritis (OA) Disease Progression Measured by MRI, dGEMRIC, and Radiography
Schnitzer, T. J. (PD/PI)
NorthShore University HealthSystem Research Institute, Pfizer Inc.
5/5/05 → 2/29/08
Project: Research project
-
Prot# CZOL446H2315: A Multicenter, Randomized, Double-Blind, Double-Dummy Study to Determine the Rapidity of Onset of Zoledronic Acid Compared to Alendronate in Post-Menopausal Women with Moderate/Severe Osteopenia or Osteoporosis
Schnitzer, T. J. (PD/PI)
Parexel, Novartis Pharmaceuticals Corporation
2/25/05 → 5/25/05
Project: Research project
-
Prot# CZOL446H2315: A Multicenter, Randomized, Double-Blind, Double-Dummy Study to Determine the Rapidity of Onset of Zoledronic Acid Compared to Alendronate in Post-Menopausal Women with Moderate/Severe Osteopenia or Osteoporosis
Schnitzer, T. J. (PD/PI)
Parexel, Novartis Pharmaceuticals Corporation
2/25/05 → 5/25/05
Project: Research project
-
Prot# CZOL446H2315: A Multicenter, Randomized, Double-Blind, Double-Dummy Study to Determine the Rapidity of Onset of Zoledronic Acid Compared to Alendronate in Post-Menopausal Women with Moderate/Severe Osteopenia or Osteoporosis
Schnitzer, T. J. (PD/PI)
Parexel, Novartis Pharmaceuticals Corporation
2/25/05 → 5/25/05
Project: Research project
-
Prot# CZOL446H2315: A Multicenter, Randomized, Double-Blind, Double-Dummy Study to Determine the Rapidity of Onset of Zoledronic Acid Compared to Alendronate in Post-Menopausal Women with Moderate/Severe Osteopenia or Osteoporosis
Schnitzer, T. J. (PD/PI)
Parexel, Novartis Pharmaceuticals Corporation
2/25/05 → 5/25/05
Project: Research project
-
Prot# CCOX189A2367: A 13-Week, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Trial of Lumiracoxib (COX189) 100mg o.d. in Patients with Primary Hip Osteoarthritis Using Celecoxib (200mg o.d.) as a Positive Control
Schnitzer, T. J. (PD/PI)
Novartis Pharmaceuticals Corporation
10/1/04 → 3/31/07
Project: Research project
-
Prot# CCOX189A2367: A 13-Week, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Trial of Lumiracoxib (COX189) 100mg o.d. in Patients with Primary Hip Osteoarthritis Using Celecoxib (200mg o.d.) as a Positive Control
Schnitzer, T. J. (PD/PI)
Novartis Pharmaceuticals Corporation
10/1/04 → 3/31/07
Project: Research project
-
Prot#211-00/FOS 530: Rndmzd, Dbl-Blind, Dbl-Dummy, Prll-Grp, Mlticntr Stdy to Eval & Comp Effects of 1x Wkly Alendronate & Risedronate on Bone Mineral Density in Postmenopausal Women w/Osteoporosis (FACT - FOSAMAX® ACTONEL® Comparison Trial)
Schnitzer, T. J. (PD/PI)
NorthShore University HealthSystem Research Institute, Merck & Co., Inc.
8/23/04 → 12/31/05
Project: Research project
-
Prot# CZOL446M2308: Randomized, Multicenter, Double-Blind, Double-Dummy, Parallel Group Study to Determine the Efficacy & Safety of Intravenous Zoledronic Acid 5mg Annually Compared to Oral Alendronate 70mg Weekly for the Treatment of Osteoporosis in Men
Schnitzer, T. J. (PD/PI)
Parexel, Novartis Pharmaceuticals Corporation
7/2/04 → 6/20/08
Project: Research project
-
Prot# CZOL446M2308: Randomized, Multicenter, Double-Blind, Double-Dummy, Parallel Group Study to Determine the Efficacy & Safety of Intravenous Zoledronic Acid 5mg Annually Compared to Oral Alendronate 70mg Weekly for the Treatment of Osteoporosis in Men
Schnitzer, T. J. (PD/PI)
Parexel, Novartis Pharmaceuticals Corporation
7/2/04 → 6/20/08
Project: Research project
-
Prot# CZOL446H2315: A Multicenter, Randomized, Double-Blind, Double-Dummy Study to Determine the Rapidity of Onset of Zoledronic Acid Compared to Alendronate in Post-Menopausal Women with Moderate/Severe Osteopenia or Osteoporosis
Schnitzer, T. J. (PD/PI)
Parexel, Novartis Pharmaceuticals Corporation
4/15/04 → 4/27/07
Project: Research project
-
Prot# WL-1001-05-04: An Open Label Multicenter Study Evaluating the Safety of Civamide Cream 0.075% as a Treatment in Subjects with Osteoarthritis of the Knee(s)
Schnitzer, T. J. (PD/PI)
3/23/04 → 12/31/06
Project: Research project